Validation of γ-actin as a potential target in breast cancer

被引：0
|
作者：
Shahbazi, RI
McCann, A
Frawley, A
Doran, P
Chung, WY
Dervan, P
Kerin, MJ
机构：
[1] Mater Misericordiae Hosp, Dept Surg, Dublin 7, Ireland
[2] Mater Misericordiae Hosp, Dept Pathol, Dublin 7, Ireland
[3] Mater Misericordiae Hosp, Human Genomics & Bioinformat Res Unit, Dublin 7, Ireland
[4] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2004年 / 91卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1216 / 1216
页数：1
相关论文
共 50 条
  • [21] Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development
    Zhang, Tianshu
    Zhou, Huimin
    Wang, Kexin
    Wang, Xiaowei
    Wang, Mengyan
    Zhao, Wenxia
    Xi, Xiaoming
    Li, Yang
    Cai, Meilian
    Zhao, Wuli
    Xu, Yanni
    Shao, Rongguang
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [22] Conditional transgenic models for breast cancer progression and target validation.
    Chodosh, LA
    Boxer, RB
    Moody, SE
    Keister, BA
    Jang, JW
    Sarkisian, CJ
    Belka, GK
    Blakely, CM
    Portocarero, CP
    Sterner, CJ
    Notar-Francesco, KL
    Kauh, EA
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6273S - 6273S
  • [23] Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
    Wali, Vikram B.
    Patwardhan, Gauri A.
    Pelekanou, Vasiliki
    Karn, Thomas
    Cao, Jian
    Ocana, Alberto
    Yan, Qin
    Nelson, Bryce
    Hatzis, Christos
    Pusztai, Lajos
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
    Vikram B. Wali
    Gauri A. Patwardhan
    Vasiliki Pelekanou
    Thomas Karn
    Jian Cao
    Alberto Ocana
    Qin Yan
    Bryce Nelson
    Christos Hatzis
    Lajos Pusztai
    Scientific Reports, 9
  • [25] Lipocalin 2: a potential therapeutic target for breast cancer metastasis
    Hu, Chenxia
    Yang, Ke
    Li, Mengjie
    Huang, Weiping
    Zhang, Fengxue
    Wang, Hongqi
    ONCOTARGETS AND THERAPY, 2018, 11 : 8099 - 8106
  • [26] The tissue transglutaminase: a potential target regulating MDR in breast cancer
    Cheng, K.
    Wang, X-H
    Hua, Y-T
    Zhang, Y-Z
    Han, Y.
    Yang, Z-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (11) : 6175 - 6184
  • [27] Potential therapeutic target for triple-negative breast cancer
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2012, 13 (08): : E330 - E330
  • [28] Tau and stathmin proteins in breast cancer: A potential therapeutic target
    Yang, Hanzhao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (04) : 445 - 452
  • [29] CEMIP as a potential biomarker and therapeutic target for breast cancer patients
    Xue, Jinqi
    Zhu, Xudong
    Qiao, Xinbo
    Wang, Yulun
    Bu, Jiawen
    Zhang, Xiaoying
    Ma, Qingtian
    Liang, Lu
    Sun, Lisha
    Liu, Caigang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (03): : 434 - 445
  • [30] TYRO3 as a Potential Therapeutic Target in Breast Cancer
    Ekyalongo, Roudy Chiminch
    Mukohara, Toru
    Funakoshi, Yohei
    Tomioka, Hideo
    Kataoka, Yu
    Shimono, Yohei
    Chayahara, Naoko
    Toyoda, Masanori
    Kiyota, Naomi
    Minami, Hironobu
    ANTICANCER RESEARCH, 2014, 34 (07) : 3337 - 3345
12345